Carregant...
A systematic review: the appraisal of the effects of metformin on lipoprotein modification and function
AIMS: Metformin is a commonly prescribed anti‐hyperglycaemic pharmacological agent, and it remains a staple in the management of type II diabetes. In addition to metformin's glucose lowering effects, research has indicated that metformin inhibits glycation‐mediated and oxidative modification of...
Guardat en:
| Publicat a: | Obes Sci Pract |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6381305/ https://ncbi.nlm.nih.gov/pubmed/30820329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/osp4.309 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|